All News | Regulatory

CONTROLLED SUBSTANCES NEWS

Jul 13, 2020
Doctor Excluded from Federal Health Care Programs for CSA Violations Pleads Guilty to Fraud Charges
Jul 10, 2020
Conn. Pharmacy Agrees To Pay $150,000 Civil Penalty Following Discovery of Inventory Discrepancy
Jul 7, 2020
Pharmacist Sentenced to Four Years in Prison for Health Care Fraud Conspiracy, Illegal Distribution
Jun 19, 2020
Another Synthetic Opioid Under Temporary Schedule I Control
Jun 19, 2020
Two Anabolic Steroid Products Exempted from Control
Jun 10, 2020
Pharmacy Agrees to Pay Civil Monetary Penalties in Dispute Over Allegedly Invalid Prescriptions
Jun 9, 2020
W.Va. Pharmacy Sentenced on Money Laundering Charges Arising From Conspiracy with Pain Clinic
Jun 8, 2020
Omnicare Agrees To Pay $15.3 Million To Resolve Allegations of Violations at Long-Term Care Facilities
Jun 8, 2020
Ethylone Now Listed Separately from Butylone
May 18, 2020
Rulemakings Initiated for Two Substances Undergoing International Control
May 1, 2020
Exclusion from Federal Health Programs Does Not Mandate DEA Registration Revocation, Denial
Apr 24, 2020
Electronic Prescription Regulations Under Review
Apr 23, 2020
Norfentanyl Designated as Fentanyl Immediate Precursor, Placed in Schedule II
Apr 22, 2020
Final Rule Adds Two Chemicals to List I
Apr 21, 2020
COVID-19 Public Health Emergency Requires Adjustment to the 2020 Quotas, Moving the Effective Date for Temporary Placement of Fentanyl-Related Substances
Apr 21, 2020
Expedited Scheduling Places New Sleep Aid in Schedule IV
Apr 20, 2020
Proposal Would Place Synthetic Stimulant Drug in Schedule I
Apr 12, 2020
Final Order Forfeits Seized Inventory in Long-standing Revocation Action
Apr 5, 2020
DEA Seeks to Ensure Supply Chain Continuation and Patient Access Via Telemedicine During COVID-19 Pandemic
Mar 31, 2020
Synthetic Cannabinoid FUB-AMB Permanent in Schedule I
Mar 27, 2020
Registration Fee Adjustments Proposed
Mar 22, 2020
DEA Proposes Rules for Bulk Manufacture of Cannabis for Research
Mar 17, 2020
Detroit Clinic Owner Sentenced to Prison
Mar 12, 2020
Newly Approved Anticonvulsant to Schedule V
Mar 8, 2020
USDA Delays DEA Registration Rule for Hemp-Testing Labs

Copyright © Thompson Controlled Subtances, a division of CBIS. All rights reserved.